Perbedaan Indo Pureco Pratama Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Indo Pureco Pratama Tbk. diperdagangkan di Rp14 (kapitalisasi pasar 64,4 M), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Brigit Biofarmaka Teknologi Tbk. jauh lebih besar — sekitar 2,6× kapitalisasi pasar Indo Pureco Pratama Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IPPE | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 64,4 M | 166,01 M |
Volume | — | 324 rb |
Lot | — | 3,24 rb |
Perputaran | — | 77,68 jt |
Harga Rata-rata | — | 239,75 |
Nilai Transaksi | — | 77,68 jt |
Harga Ekuilibrium Indikatif | — | 240 |
Volume Ekuilibrium Indikatif | — | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indo Pureco Pratama Tbk ("the Company") was established based on Notarial Deed No. 839 dated March 20, 2019, by Joice Hapsari Fendrini, S.H., M.Kn., Notary in Subang. The Company started its commercial operations in March 2019. The Company has coconut flesh processing factory located at Balimbing, Sub-District Pagaden Barat, District Subang, West Java, Indonesia.
Selengkapnya di halaman IPPE →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →